These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| ☒ |
Definitive Proxy Statement
|
| ☐ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material Pursuant to §240.14a-12
|
|
Lincoln Educational Services Corporation
|
|
(Name of Registrant as Specified In Its Charter)
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
| ☒ |
No fee required.
|
| ☐ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
| ☐ |
Fee paid previously with preliminary materials.
|
| ☐ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
|
Sincerely,
|
|
|
|
|
|
Scott M. Shaw
|
|
|
Chief Executive Officer
|
|
|
1. |
to elect eight directors identified in this proxy statement to serve until the next annual meeting of shareholders following their election and until their respective successors are duly elected and qualify;
|
|
|
2. |
to approve, on a non-binding advisory basis, the Company’s compensation of its named executive officers (a “say on pay” vote);
|
|
|
3. |
to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for our fiscal year ending December 31, 2021; and
|
|
|
4. |
to transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof and may properly be voted upon.
|
|
By Order of the Board of Directors
|
|
|
|
|
Parsippany, New Jersey
|
Alexandra M. Luster
|
|
March 26, 2021
|
Corporate Secretary
|
|
1
|
|
|
6
|
|
|
|
|
|
6
|
|
|
8
|
|
|
9
|
|
|
12
|
|
|
12
|
|
|
12
|
|
|
13
|
|
|
17
|
|
|
17
|
|
|
23
|
|
|
24
|
|
|
29
|
|
|
30
|
|
|
31
|
|
|
|
|
|
32
|
|
|
|
|
|
32
|
|
|
32
|
|
|
33
|
|
|
33
|
|
|
33
|
|
|
34
|
|
|
34
|
|
|
34
|
|
|
• |
election of eight directors to serve until the next annual meeting of shareholders following their election and until their respective successors are duly elected and qualify;
|
|
|
• |
to approve, on a non-binding advisory basis, the compensation of the named executive officers (“say on pay”), as described in these proxy materials; and
|
|
|
• |
ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.
|
|
|
• |
FOR
the election of each of the eight director nominees to be elected by holders of shares of Common Stock and shares of Series A Preferred Stock, voting together as a single class;
|
|
|
• |
FOR
the election of the director nominee to be elected exclusively by the holders of Series A Preferred Stock voting separately as a class;
|
|
|
• |
FOR
the approval, on a non-binding advisory basis, the compensation of the named executive officers (“say on pay”), as described in these proxy materials; and
|
|
|
• |
FOR
ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.
|
|
|
• |
authorizing a new proxy on the Internet or by telephone;
|
|
|
• |
properly executing and delivering a later-dated (i.e., subsequent to the date of the original proxy) proxy card so that it is received no later than May 5, 2021;
|
|
|
• |
voting at the Annual Meeting; or
|
|
|
• |
sending a written notice of revocation to the inspector of election in care of the Corporate Secretary of the Company at 14 Sylvan Way, Parsippany NJ 07054 so that it is received no later than May 5, 2021.
|
|
Name
|
Age
|
Position Held
|
||
|
J. Barry Morrow
|
68
|
Non-Executive Chairman of the Board of Directors
|
||
|
John A. Bartholdson (1) (2) (3)
|
50
|
Series A Preferred Stock Director
|
||
|
James J. Burke, Jr. (1) (3)
|
69
|
Director
|
||
|
Kevin M. Carney (2)
|
56
|
Director
|
||
|
Celia H. Currin (2) (3)
|
72
|
Director
|
||
|
Ronald E. Harbour (1) (3)
|
64
|
Director
|
||
|
Michael A. Plater, PhD. (3)
|
64
|
Director
|
||
|
Carlton E. Rose (1)
|
59
|
Director
|
||
|
Scott M. Shaw
|
58
|
Chief Executive Officer, Director
|
||
|
Brian K. Meyers
|
53
|
Executive Vice President, Chief Financial Officer and Treasurer
|
||
|
Stephen M. Buchenot
|
65
|
Executive Vice President of Campus Operations
|
|
Director
|
CEO/
Senior
Officer
(1)
|
Industry Experience
(2)
|
Governance/
Board
Experience
(3)
|
Financial
Acumen
(4)
|
Business
Development/
M&A
Experience
(5)
|
Independent
(6)
|
Diversity
(Gender/
Racial/
Ethnic)
(7)
|
|
John A. Bartholdson
|
✓ | ✓ | ✓ |
✓
|
|||
|
James J. Burke, Jr.
|
✓ | ✓ | ✓ | ✓ | ✓ |
✓
|
|
|
Kevin M. Carney
|
✓ | ✓ | ✓ | ✓ |
✓
|
||
|
Celia H. Currin
|
✓ | ✓ | ✓ |
✓
|
|||
|
Ronald E. Harbour
|
✓ | ✓ | ✓ | ✓ | ✓ | ||
|
J. Barry Morrow
|
✓ | ✓ | ✓ | ✓ |
✓
|
||
|
Michael A. Plater, PhD
|
✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
|
Carlton E. Rose
|
✓ | ✓ | ✓ | ✓ | ✓ | ||
|
Scott M. Shaw
|
✓ | ✓ | ✓ | ✓ | ✓ |
| (1) |
CEO/Senior Officer – Experience working as a CEO or senior officer of an organization.
|
| (2) |
Industry Experience – Senior executive experience in one or more of the Company’s primary or related industries.
|
| (3) |
Governance/Board Experience – Prior or current experience as a board member of an organization (public, private, or non-profit sectors).
|
| (4) |
Financial Acumen – Experience in financial accounting and reporting, including persons designated by the Board of Directors as audit committee financial experts. Familiarity with internal financial controls. Also includes
professional experience in corporate finance, especially with respect to debt and equity markets.
|
| (5) |
Business Development/ M&A Experience – Experience with business development, mergers and acquisitions and/or divestitures.
|
| (6) |
Independent – Determined by the Board of Directors to be an independent director. See “Director Independence”.
|
| (7) |
Diversity – Denotes gender, racial or ethnic diversity. See “Board Diversity”.
|
|
Name
|
Audit
|
Nominating and
Corporate Governance
|
Compensation
|
|
John A. Bartholdson
|
✓ | ✓ | ✓ |
|
Peter S. Burgess
|
Chair
|
||
|
James J. Burke, Jr.
|
✓ |
Chair
|
|
|
Kevin M. Carney
|
✓ | ||
|
Celia H. Currin
|
✓ |
Chair
|
|
|
Ronald E. Harbour
|
✓ | ✓ | |
|
J. Barry Morrow
|
|||
|
Michael A. Plater, PhD.
|
✓ | ||
|
Carlton E. Rose
|
✓ | ||
|
Scott M. Shaw
|
|||
|
2020 Meetings
|
4
|
3
|
2
|
|
|
• |
understanding the key drivers of success for our business and the associated major risks inherent in our operations and corporate strategy;
|
|
|
• |
overseeing that appropriate risk management and control procedures are implemented by management and developing and maintaining an effective risk dialogue with management; and
|
|
|
• |
crafting the right Board of Directors for our Company, including ensuring that the Board of Directors has the right mix of background, skills and experience and an appropriate committee structure to carry out its oversight
responsibilities effectively.
|
|
|
• |
none of the members of the Compensation Committee was an officer (or former officer) or employee of the Company or any of its subsidiaries;
|
|
|
• |
none of the members of the Compensation Committee had a direct or indirect material interest in any transaction in which the Company was a participant and the amount involved exceeded $120,000, except for Mr. Bartholdson who has an
interest in the shares of Common Stock and Series A Preferred Stock beneficially owned by Juniper Fund and Juniper Opportunities Fund including the dividends paid thereon. See “Transactions with Related Persons” below;
|
|
|
• |
none of the Company’s executive officers served on the compensation committee (or another board committee with similar functions or, if none, the entire board of directors) of another entity where one of that entity’s executive
officers served on the Company’s Compensation Committee;
|
|
|
• |
none of the Company’s executive officers was a director of another entity where one of that entity’s executive officers served on the Company’s Compensation Committee; and
|
|
|
• |
none of the Company’s executive officers served on the compensation committee (or another board committee with similar functions or, if none, the entire board of directors) of another entity where one of that entity’s executive
officers served as a director on the Company’s Board of Directors.
|
|
Name and Address of Beneficial Owner
|
Common Stock
|
Series A Preferred Stock
|
||||
|
Number of
Shares
Beneficially
Owned (1)
|
% of Class
(1)
|
Number of
Shares
Beneficially
Owned (1)
|
% of Class
(1)
|
|||
|
Juniper Investment Company, LLC (2)
555 Madison Avenue, 24
th
Floor
New York, NY 10022
|
5,346,244 (2)
|
16.8% (2)
|
11,200 (3)
|
88.2% (3)
|
||
|
Heartland Advisors, Inc. (4)
789 North Water Street, Suite 1200
Milwaukee, WI 53202
|
2,744,774
|
10.2%
|
||||
|
Talanta Investment Group, LLC (5)
401 N. Tryon Street, 10
th
Floor
Charlotte, NC 28202
|
2,421,676 (5)
|
8.8% (5)
|
1,500 (5)
|
11.8% (5)
|
||
|
Alyeska Investment Group, L.P. (6)
77 West Wacker Drive, 7
th
floor
Chicago, IL 60601
|
2,352,919
|
8.7%
|
||||
|
Paradice Investment Management, LLC. (7)
257 Fillmore Street, Suite 200
Denver, CO 80206
|
2,274,364
|
8.4%
|
||||
|
22NW, LP (8)
1455 NW Leary Way, Suite 400
Seattle, WA 98107
|
2,062,651
|
7.6%
|
||||
|
Nantahala Capital Management, LLC (9)
130 Main Street, 2
nd
Floor
New Canaan, CT 06840
|
1,555,022
|
5.8%
|
||||
| (1) |
As of the close of business on March 8, 2021, the Record Date, there were 26,988,965 shares of our Common Stock and 12,700 shares of our Series A Preferred Stock outstanding and entitled to vote at the Annual Meeting. Each share of
Common Stock is entitled to one vote on each matter voted upon. Holders of Series A Preferred Stock are entitled to vote with the holders of Common Stock, on an as-converted basis and not as a separate class, on all matters except the
election of the Series A Preferred Stock Director, which will be determined solely by the holders of our Series A Preferred Stock. As of March 8, 2021, each share of Series A Preferred Stock may be converted into 423.729 shares of
Common Stock or an aggregate of 5,381,356 shares of Common Stock.
|
| (2) |
Based on information in a statement on Schedule 13D filed with the SEC on November 22, 2019 by Juniper Investment Company, LLC and a subsequent SEC filing on September 18, 2020 on Form 4. Juniper Investment Company, LLC (“Juniper
Investment Company”) is the investment advisor to Juniper Targeted Opportunities Fund, L.P. (“Juniper Targeted Opportunities”) and Juniper Targeted Opportunity Fund, L.P. (“Juniper Fund”). Juniper Targeted Opportunities holds 7,700 shares
of Series A Preferred Stock which is entitled to vote 3,262,712 Conversion Shares issuable upon conversion of such shares of Series A Preferred Stock on all matters being considered by the holders of our Common Stock. Juniper Fund holds
563,274 shares of Common Stock and 3,500 shares of Series A Preferred Stock which is entitled to vote 1,483,051 Conversion Shares issuable upon conversion of such shares of Series A Preferred Stock on all matters being considered by the
holders of our Common Stock. Each of Alexis P. Michas and John A. Bartholdson serves as the managing member of Juniper Investment Company and the general partners of Juniper Targeted Opportunities and the Juniper Fund and as a result each
of Juniper Investment Company, Mr. Michas and Mr. Bartholdson share voting and dispositive power over an aggregate of 5,309,037 Common Shares as follows (i) 563,274 shares of Common Stock held by Juniper Fund and (ii) an aggregate of
4,745,763 Conversion Shares held by Juniper Targeted Opportunities and the Juniper Fund on the Record Date. In addition, Mr. Michas and Mr. Bartholdson owns 16,393 shares and 20,814 shares of Common Stock, respectively. For purposes of
calculating the ownership percentage of Common Stock, the 5,346,244 Common Shares listed under Juniper Investment Company (which includes the shares of Common Stock held by Mr. Michas and Mr. Bartholdson) were divided by the sum of
26,988,965 shares of Common Stock outstanding on the record date and 4,745,763 Conversion Shares issuable upon conversion of the Series A Preferred Stock held by Juniper Targeted Opportunities and Juniper Fund
.
|
| (3) |
Juniper Investment Company is the investment advisor to Juniper Targeted Opportunities and Juniper Fund which holds 7,700 shares and 3,500 shares, of Series A Preferred Stock, respectively. Each of Alexis P. Michas and John A.
Bartholdson serves as the managing member of Juniper Investment Company and the general partners of Juniper Targeted Opportunities and the Juniper Fund. Each of Mr. Michas, Mr. Bartholdson and Juniper Investment Company share voting and
dispositive power over 11,200 shares of Series A Preferred Stock and the 4,745,763 Conversion Shares issuable upon conversion of the Series A Preferred Stock held on the record date by Juniper Targeted Opportunities and Juniper Fund.
|
| (4) |
Based on the information reported in a statement on Schedule 13G/A filed with the SEC on February 2, 2021 by Heartland Advisors, Inc. (“Heartland”) and William J. Nasgovitz. The amendment states that Heartland, a registered investment
advisor, and William J. Nasgovitz have shared voting power as to 2,736,774 of these shares and shared dispositive power as to all of these shares.
We have not attempted to independently verify any of
the foregoing information, which is based solely upon the information contained in the Schedule 13G/A.
|
| (5) |
Based on the information in a statement on Schedule 13D/A filed with the SEC on November 14, 2019 by Talanta Investment Group, LLC, (“Talanta Investment”). Talanta Fund, L.P. (“Talanta Fund”) holds 1,786,083 shares of Common Stock and
1,500 shares of Series A Preferred Stock, which is entitled to vote 635,593 Conversion Shares issuable upon conversion of such shares of Series A Preferred Stock on all matters being considered by the holders of our Common Stock. Talanta
Investment is the general partner of Talanta Fund and Justyn R. Putnam is the managing member of Talanta Investment. We have not attempted to independently verify any of the foregoing information, which is based solely upon the
information contained in the Schedule 13D/A.
|
| (6) |
Based on the information reported in a statement on Schedule 13G filed with the SEC on February 16, 2021 by Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, Alyeska Fund Group 2 GP, LLC (collectively, “Alyeska”) and Anand Parekh.
The amendment states that Alyeska and Anand Parekh have shared voting and dispositive power as to all of these shares.
We have not attempted to independently
verify any of the foregoing
information, which is based solely upon the information contained in the Schedule 13G.
|
| (7) |
Based on the information reported in a statement on Schedule 13G/A filed with the SEC on February 16, 2021 by Paradice Investment Management LLC (“Paradice LLC”) and Paradice Investment Management Pty Ltd (“Paradice Ltd”). The
amendment states that Paradice LLC and Paradice Ltd have shared voting power as to 1,647,063 of these shares and shared dispositive power as to all of these shares. The principal business office address of Paradice LLC is 257 Fillmore
Street, Suite 200, Denver, CO 80206. We have not attempted to independently verify any of the foregoing information, which is based solely upon the information contained in the Schedule 13G/A.
|
| (8) |
Based on the information in a statement on Schedule 13G filed with the SEC on February 12, 2021 by 22NW, LP (“22NW”). The Schedule 13G indicates that 22NW has sole voting and sole dispositive power as to all of these shares. We have
not attempted to independently verify any of the foregoing information, which is based solely upon the information contained in the Schedule 13G.
|
| (9) |
Based on the information reported in a statement on Schedule 13G/A filed with the SEC on February 12, 2021 by Nantahala Capital Management, LLC (“Nantahala”), Wilmot B. Harkey and Daniel Mack. The amendment states that Nantahala and
Messrs. Harkey and Mack have shared voting and dispositive power as to all of these shares. We have not attempted to independently verify any of the foregoing information, which is based solely upon the information contained in the
Schedule 13G/A.
|
|
Name of Beneficial Owner (1)
|
|
Number of Shares of Common
Stock Beneficially Owned (1)
|
Percent of Common Stock
Beneficially Owned (1)
|
|
|
Named Executive Officers
|
||||
|
Scott M. Shaw (2)
|
879,328
|
3.3%
|
||
|
Brian K. Meyers (3)
|
321,507
|
1.2%
|
||
|
Stephen M. Buchenot (4)
|
246,380
|
*
|
||
|
Non-Employee Directors
|
||||
|
J. Barry Morrow (5)
|
211,880
|
*
|
||
|
John A. Bartholdson (6)
|
5,329,851
|
16.8%
|
||
|
Peter S. Burgess (7)
|
158,846
|
*
|
||
|
James J. Burke, Jr. (8)
|
228,881
|
*
|
||
|
Kevin M. Carney (9)
|
12,762
|
*
|
||
|
Celia H. Currin (10)
|
158,244
|
*
|
||
|
Ronald E. Harbour (11)
|
65,847
|
*
|
||
|
Michael A. Plater, PhD. (12)
|
8,548
|
*
|
||
|
Carlton E. Rose (13)
|
8,548
|
*
|
||
|
All executive officers and directors as a group (12 persons)
|
|
7,630,622
|
|
24.0%
|
| * |
Less than 1%.
|
| (1) |
Applicable percentages are based on 26,988,965 shares of Common Stock outstanding as of March 8, 2021, except for Mr. Bartholdson and all executive officers and directors as a group, which also includes 4,745,763 Conversion Shares
issuable upon conversion of the Series A Preferred Stock held by Juniper Targeted Opportunities and Juniper Fund. For purposes of this table, (i) shares of restricted Common Stock that have not vested are included in the shares
outstanding as of the Record Date and are entitled to be voted, (ii) a person or group of persons is deemed to have “beneficial ownership” of any shares as of a given date that such person or group has the right to acquire within 60 days
after such date and (iii) unless otherwise stated, the address for each named person is 14 Sylvan Way, Parsippany, NJ 07054
|
| (2) |
Includes (i) 567,277 shares of Common Stock held by Mr. Shaw and (ii) 312,051 shares of restricted Common Stock.
|
| (3) |
Includes (i) 105,218 shares of Common Stock held by Mr. Meyers and (ii) 216,289 shares of restricted Common Stock.
|
| (4) |
Includes (i) 76,100 shares of Common Stock held by Mr. Buchenot and (ii) 170,280 shares of restricted Common Stock.
|
| (5) |
Includes (i) 189,838 shares of Common Stock held by Mr. Morrow and (ii) 22,042 shares of restricted Common Stock.
|
| (6) |
Includes (i) 8,052 shares of Common Stock held by Mr. Bartholdson and (ii) 563,274 shares of Common Stock held by Juniper Fund and (iii) 4,745,763 Conversion Shares issuable upon conversion of the 11,200 shares of Series A Preferred
Stock held by Juniper Targeted Opportunities and Juniper Fund on the record date, over which Mr. Bartholdson shares voting and dispositive power with Mr. Michas and Juniper Investment Company. The principal business office address of Mr.
Bartholdson is 555 Madison Avenue, 24th Floor, New York, NY 10022.
|
| (7) |
Includes (i) 146,084 shares of Common Stock held by Mr. Burgess and (ii) 12,762 shares of restricted Common Stock.
|
| (8) |
Includes (i) 216,119 shares of Common Stock held by Mr. Burke and (ii) 12,762 shares of restricted Common Stock.
|
| (9) |
Includes 12,762 shares of restricted Common Stock held by Mr. Carney.
|
| (10) |
Includes (i) 145,482 shares of Common Stock held by Ms. Currin and (ii) 12,762 shares of restricted Common Stock.
|
| (11) |
Includes (i) 53,085 shares of Common Stock held by Mr. Harbour and (ii) 12,762 shares of restricted Common Stock.
|
| (12) |
Includes 8,548 shares of restricted Common Stock held by Dr. Plater.
|
| (13) |
Includes 8,548 shares of restricted Common Stock held by Mr. Rose.
|
|
Plan Category
|
Number of
Securities to be
issued upon
exercise of
outstanding
options,
warrants and
rights
|
Weighted-
average
exercise
price of
outstanding
options,
warrants and
rights
|
Number of
securities
remaining
available for
future issuance
under equity
compensation
plans (excluding
securities
reflected in
column (1))
|
|||||||||
|
(1)
|
|
|||||||||||
|
Equity compensation plans approved by security holders
|
81,000
|
$
|
7.79
|
2,131,922
|
||||||||
|
Equity compensation plans not approved by security holders
|
-
|
-
|
-
|
|||||||||
|
Total
|
81,000
|
$
|
7.79
|
2,131,922
|
||||||||
|
|
• |
Scott M. Shaw, our President and Chief Executive Officer;
|
|
|
• |
Brian K. Meyers, our Executive Vice President, Chief Financial Officer and Treasurer;
|
|
|
• |
Stephen M. Buchenot, our Executive Vice President of Campus Operations.
|
|
|
• |
In fiscal year 2020, performance-based restricted stock comprised 100% of our equity compensation and vests based upon the attainment of compliance metric targets set by the Compensation Committee each year during the applicable
three-year performance period. The terms of these awards are described in more detail below under “Long-Term Stock Incentives.”
|
|
|
• |
In fiscal year 2019, the Company did not award any performance-based or time-based restricted stock.
|
|
|
• |
We maintain an annual performance-based Management Incentive Compensation Plan (the “MIC Plan”). Payments under the MIC Plan are based on the attainment of predetermined net income, revenue and company-wide quality focused outcome
targets. The terms of these awards are described in more detail below under “2020 Annual Performance-Based Incentive Compensation.”
|
|
|
◾ |
In fiscal year 2020, our NEOs received payment of 150.0% of their MIC Plan target award opportunity.
|
|
|
◾ |
In fiscal year 2019, our NEOs received payment of 42.4% of their MIC Plan target award opportunity.
|
|
|
◾ |
eliminating the individual performance component of our annual incentive compensation plan and adding a component linked to company-wide quality focused outcomes that directly impact the Company’s overall health and viability;
|
|
|
◾ |
capping the maximum amount payable under the annual incentive compensation plan at 200% of target; and
|
|
|
◾ |
granting performance-based restricted stock that vests upon the attainment of EBITDA targets during each year.
|
|
|
• |
Cap on Annual Incentive Compensation.
The aggregate maximum annual incentive award that can be earned by each of our named executive officers is capped at 200% of their target.
|
|
|
• |
No Executive Retirement Programs.
We do not maintain enhanced retirement arrangements for our executive officers. Executive officers are eligible to participate in our 401(k) plan in the same
manner as all other employees.
|
|
|
• |
No tax gross-ups.
As discussed below under the heading “Employment Agreements and Change in Control Benefits,” we do not provide our executive officers with tax gross-ups for “excess parachute
payments” upon a change in control.
|
|
Performance Measure
|
Percentage of Total Incentive
Compensation Opportunity
|
|
Net Income/Loss
|
47%
|
|
Revenue
|
33%
|
|
Company-Wide Quality Focused Outcomes
|
20%
|
|
Named Executive Officer
|
Target 2020 MIC Plan Award ($)
|
Total 2020 MIC Plan
Payment ($)
|
|
Scott M. Shaw
|
500,000
|
750,000
|
|
Brian K. Meyers
|
269,216
|
403,824
|
|
Stephen M. Buchenot
|
152,194
|
228,290
|
|
2U, Inc.
|
K12 Inc.
|
|
Adtalem Global Education Inc.
|
Strategic Education, Inc.
|
|
American Public Education, Inc.
|
Universal Technical Institute, Inc.
|
|
Career Education Corporation
|
Zovio, Inc.
|
|
Grand Canyon Education, Inc.
|
|
COMPENSATION COMMITTEE
|
|
|
James J. Burke, Chair
|
|
|
John A. Bartholdson
|
|
|
Ronald E. Harbour
|
|
|
Carlton E. Rose
|
|
Name and Principal Position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock Awards
($)
(1)
|
Non-Equity Incentive Plan Compensation
($)
(2)
|
All Other Compensation
($)
|
Total
($)
|
|
Scott M. Shaw
|
2020
|
500,000
|
-
|
498,000
|
750,000
|
8,168
|
1,756,168
|
|
President and
|
2019
|
500,000
|
10,000
|
250,000
|
211,805
|
5,241
|
977,046
|
|
Chief Executive Officer
|
|||||||
|
Brian K. Meyers
|
2020
|
358,955
|
-
|
398,400
|
403,824
|
5,677
|
1,166,856
|
|
Executive Vice President, Chief
|
2019
|
350,200
|
15,000
|
127,500
|
111,261
|
4,957
|
608,918
|
|
Financial Officer and Treasurer
|
|
||||||
|
Stephen M. Buchenot
|
2020
|
304,387
|
-
|
298,800
|
228,290
|
5,475
|
836,952
|
|
Executive Vice President of
|
2019
|
289,893
|
-
|
70,361
|
61,401
|
4,219
|
425,874
|
|
Campus Operations
|
|
||||||
|
|
(1) |
For fiscal year 2020, represents the aggregate grant date fair value of performance-based restricted stock awards on February 20, 2020. The fair values of these grants were determined in accordance with
Financial Accounting Standards Board Accounting Standards Code Topic 718 (excluding the effect of estimated forfeitures). See Note 10 to the audited consolidated financial statements in our Annual Report on Form 10-K for the fiscal year
ended December 31, 2020 filed with the SEC regarding assumptions underlying the valuation of equity awards. Whether, and to what extent, a named executive officer realizes value will depend on our actual operating performance, stock
price fluctuations and the named executive officer’s continued employment. Amounts reported for these awards may not represent the amounts that the named executive officers will actually realize from the awards. The terms and conditions
of the performance-based restricted stock awards are described in the “Compensation Discussion and Analysis.”
|
|
|
(2) |
Reflects the value of cash incentive awards paid under our MIC Plan as described in the “Compensation Discussion and Analysis.”
|
|
|
(3) |
Amounts reflected in this column include the following: (a) the costs related to personal use of a company-owned vehicle for fiscal years 2020 and 2019, $2,214 for Mr. Shaw and $2,213 for Mr. Meyers; (b) premiums paid on each named
executive officer’s life insurance policy for 2020 and 2019 as follows: $3,027 for Mr. Shaw, $2,744 for Mr. Meyers and $4,219 for Mr. Buchenot; and (c)
401(k) matching contributions for each named
executive officer as follows for 2020, $2,928 for Mr. Shaw, $720 for Mr. Meyers, and $1,256 for Mr. Buchenot
.
|
|
Option Awards
|
Stock Awards
|
Stock Awards
|
|||||
|
Equity Incentive Plan Awards:
|
|||||||
|
Name
|
Number of securities underlying unexercised
options
(#)
Exercisable
|
Option exercise price
($)
|
Option expiration date
|
Number of shares
or units of stock
that have not vested
(#)
|
Market value of shares or units of stock that have not vested
($)
|
Number of shares,units or
other rights that have not vested
(#)
|
Market value of shares, or payout units or other
rights that have not vested
($)
(1)
|
|
|
|||||||
|
Scott M. Shaw
|
-
|
-
|
-
|
52,576 (1)
|
341,744
|
||
|
-
|
-
|
-
|
200,000 (2)
|
1,300,000
|
|||
|
Brian K. Meyers
|
-
|
-
|
-
|
26,814 (1)
|
174,291
|
||
|
-
|
-
|
-
|
160,000 (2)
|
1,040,000
|
|||
|
Stephen M. Buchenot
|
-
|
-
|
-
|
14,797 (1)
|
96,183
|
||
|
-
|
-
|
-
|
120,000 (2)
|
780,000
|
|||
| (1) |
All equity award values are based on a December 31, 2020 closing stock price of $6.50.
|
| (2) |
Awarded on February 28, 2019, the time-based restricted stock grant awarded to the named executive officers vests ratably on the date of grant and on each of the first through third anniversaries of the grant date.
|
| (3) |
Awarded on February 20, 2020, the performance-based restricted stock grant awarded to the named executive officer vests over three years, 20%, 30% and 50%, respectively, commencing with fiscal year 2020.
|
|
|
• |
the Executive’s Involuntary Termination (as defined below);
|
|
|
• |
a Change in Control (as defined below); or
|
|
|
• |
the Executive’s Death or Disability.
|
|
Name
|
Aggregate Severance
|
Stock Awards
|
Benefits
|
Total
|
|
($)
|
($)
|
($)
|
($)
|
|
|
(1)
|
(2)
|
|||
|
Scott M. Shaw
|
||||
|
Involuntary Termination (3)
|
2,000,000
|
1,641,744
|
20,774
|
3,662,518
|
|
Change in Control
|
-
|
1,641,744
|
-
|
1,641,744
|
|
Death or Disability (4)
|
500,000
|
1,641,744
|
-
|
2,141,744
|
|
Termination for Cause or Resignation without Good Reason
|
-
|
-
|
-
|
-
|
|
Brian Meyers
|
||||
|
Involuntary Termination (5)
|
1,099,300
|
1,214,291
|
20,031
|
2,333,622
|
|
Change in Control
|
-
|
1,214,291
|
-
|
1,214,291
|
|
Death or Disability (6)
|
269,216
|
1,214,291
|
-
|
1,483,507
|
|
Termination for Cause or Resignation without Good Reason
|
-
|
-
|
-
|
-
|
|
Stephen M. Buchenot
|
||||
|
Involuntary Termination (7)
|
684,870
|
876,182
|
26,695
|
1,587,747
|
|
Change in Control
|
-
|
876,182
|
-
|
876,182
|
|
Death or Disability (4)
|
152,193
|
876,182
|
-
|
1,028,375
|
|
Termination for Cause or Resignation without Good Reason
|
-
|
-
|
-
|
-
|
| (1) |
All outstanding stock options, restricted stock and performance-based restricted stock granted by the Company to the named executive officers will become fully vested and immediately exercisable upon (i) a Change in Control (as defined
below), (ii) an Involuntary Termination (as defined below) or (iii) upon the executive’s death or disability.
|
| (2) |
Includes a cash payment equal to the Company’s estimate of the employer portions of the premiums that would be necessary to continue the executive’s health care benefits coverage until the first anniversary of the executive’s date of
termination.
|
| (3) |
Consists of a lump sum payment equal to two times the sum of Mr. Shaw’s 2020 base salary and the target amount of his annual performance bonus for fiscal year 2020.
|
| (4) |
Includes an annual cash incentive compensation award under the MIC Plan for the year of termination based upon target levels.
|
| (5) |
Consists of a lump sum payment equal to one and three-quarters times the sum of Mr. Meyers’ 2020 base salary and the target amount of his annual performance bonus for fiscal year 2020.
|
| (6) |
Consists of a lump sum payment equal to one and one-half times the sum of Mr. Buchenot’s 2020 base salary and the target amount of his annual performance bonus for fiscal year 2020.
|
|
Name
|
Fees Earned or
Paid in Cash
($)
|
Stock Awards
($)
|
Total
($)
|
|
(1)
|
|||
|
J. Barry Morrow
|
90,500
|
95,000
|
185,500
|
|
Alvin O. Austin (2)
|
45,000
|
55,000
|
100,000
|
|
John A. Bartholdson
|
46,500
|
55,000
|
101,500
|
|
James J. Burke, Jr.
|
54,500
|
55,000
|
109,500
|
|
Peter S. Burgess
|
70,000
|
55,000
|
125,000
|
|
Kevin M. Carney
|
32,000
|
55,000
|
87,000
|
|
Celia H. Currin
|
65,000
|
55,000
|
120,000
|
|
Ronald E. Harbour
|
55,000
|
55,000
|
110,000
|
|
Dr. Michael A. Plater (3)
|
14,500
|
48,125
|
62,625
|
|
Carlton E. Rose (3)
|
14,500
|
48,125
|
62,625
|
|
|
(1) |
Represents the grant date fair value of a restricted stock award granted on June 16, 2020. The fair value of this grant was determined in accordance with FASB ASC Topic 718 (excluding the effect of estimated forfeitures) as determined
based on applying the assumptions used in the Company’s financial statements. See Note 10 to the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020, regarding assumptions
underlying the valuation of equity awards.
|
|
|
(2) |
Mr. Austin retired from the Board of Directors on August 7, 2020. As such, his restricted stock award on June 16, 2020 was accelerated and fully vested based on the share fair market value of $5.63 on August 6, 2020.
|
|
|
(3) |
Dr. Plater and Mr. Rose were appointed to the Board of Directors on August 7, 2020.
|
|
AUDIT COMMITTEE
|
|
|
Peter S. Burgess, Chair
|
|
|
John A. Bartholdson
|
|
|
Kevin M. Carney
|
|
|
Celia H. Currin
|
|
Fee Category
|
2020
|
2019
|
||||||
|
Audit and Audit Related Fees
|
$
|
1,049,000
|
$
|
1,135,640
|
||||
|
Tax Fees
|
232,000
|
120,750
|
||||||
|
All Other Fees
|
8,280
|
8,280
|
||||||
|
Total Fees
|
$
|
1,289,280
|
$
|
1,264,670
|
||||
|
By Order of the Board of Directors
|
|
|
|
|
Alexandra M. Luster
|
|
|
Corporate Secretary
|
|
|
Parsippany, New Jersey
|
|
|
March 26, 2021
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|